Subject
Organic Chemistry,Drug Discovery,Biochemistry
Reference20 articles.
1. Single-Dose Escalation and Multiple-Dose Safety, Tolerability, and Pharmacokinetics of IDX899, a Candidate Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Subjects
2. Storer R, Dousson C, Alexandre F-R, Roland A. US 2006 0074054 A1.
3. Alexandre FR, Amador A, Bonaric S, et al. 236th ACS National Meeting in Philadelphia 17–21 August 2008.
4. Development of an Efficient Manufacturing Process to GSK2248761A API
5. Development and Scale-Up of a Manufacturing Route for the Non-nucleoside Reverse Transcriptase Inhibitor GSK2248761A (IDX-899): Synthesis of an Advanced Key Chiral Intermediate
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献